Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in Anterior STEMI Patients With pPCI
NCT07320625Phase 3Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of montelukast in ST-segment elevation myocardial infarction (STEMI), sponsored by Zhongshan Hospital, Fudan University. Started Feb 2026; status: recruiting.
02
Drugs
montelukast
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT07320625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07320625.